A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
- 21 December 1995
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (25) , 1657-1661
- https://doi.org/10.1056/nejm199512213332501
Abstract
Better treatments for chronic hepatitis B are needed. Lamivudine, the (-)enantiomer of 3'-thiacytidine, is a potent inhibitor of hepatitis B virus (HBV).Keywords
This publication has 15 references indexed in Scilit:
- Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis BNew England Journal of Medicine, 1995
- Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.Journal of Clinical Investigation, 1995
- Nucleoside analogs in the treatment of chronic viral hepatitis efficiency and complicationsJournal of Hepatology, 1994
- Mammalian DNA Polymerases .alpha., .beta., .gamma., .delta., and .epsilon. Incorporate Fialuridine (FIAU) Monophosphate into DNA and Are Inhibited Competitively by FIAU TriphosphateBiochemistry, 1994
- Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in cultureAntimicrobial Agents and Chemotherapy, 1994
- Phase II trial of lamivudine for chronic hepatitis BHepatology, 1993
- A Pilot Study of 2′,3′–Dideoxyinosine for the Treatment of Chronic Hepatitis BHepatology, 1992
- Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populationsHepatology, 1990
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B HepatitisAnnals of Internal Medicine, 1981